How much funding has Unity Biotechnology raised?

Unity Biotechnology has raised $116.0M in total funding, most recently a Venture Round.

When was Unity Biotechnology founded?

Unity Biotechnology was founded in 2011.

Where is Unity Biotechnology headquartered?

Unity Biotechnology is headquartered in South San Francisco, California, United States.

What industry is Unity Biotechnology in?

Unity Biotechnology operates in Biotech, Healthcare.

Unity Biotechnology

Closed

South San Francisco, United States · Founded 2011 · $116.0M raised

Biotech

Healthcare

Headquarters: South San Francisco, California
Founded: 2011
Website: unitybiotechnology.com

Total Funding: $116.0M
Last Round: $116.0M Venture RoundOct 2016
Rounds: 1

About

Unity Biotechnology was a clinical-stage biotechnology company developing senolytic medicines that selectively eliminate senescent cells to treat age-related diseases, with a primary focus on ophthalmologic conditions including diabetic macular edema. The company conducted clinical trials for its lead candidate UBX1325. Unity ceased operations in 2025.

Summary

Unity Biotechnology is a Biotech company based in South San Francisco, United States, founded in 2011. It has raised $116.0M in total across 1 round, most recently a $116.0M Venture Round round in Oct 2016.

LinkedIn X (Twitter)